×
About 2,015 results

ALLMedicine™ Optic Atrophy Center

Research & Reviews  755 results

Idiopathic Intracranial Hypertension (IIH)
https://emedicine.medscape.com/article/1214410-print

Jun 8th, 2022 - Practice Essentials Idiopathic intracranial hypertension (IIH) is a disorder of unknown etiology that predominantly affects obese women of childbearing age.[1] The primary problem is chronically elevated intracranial pressure (ICP), and the most i...

Idiopathic Intracranial Hypertension (IIH)
http://emedicine.medscape.com/article/1214410-overview

Jun 8th, 2022 - Practice Essentials Idiopathic intracranial hypertension (IIH) is a disorder of unknown etiology that predominantly affects obese women of childbearing age. [1] The primary problem is chronically elevated intracranial pressure (ICP), and the most ...

Idiopathic Intracranial Hypertension (IIH)
https://emedicine.medscape.com/article/1214410-overview

Jun 8th, 2022 - Practice Essentials Idiopathic intracranial hypertension (IIH) is a disorder of unknown etiology that predominantly affects obese women of childbearing age. [1] The primary problem is chronically elevated intracranial pressure (ICP), and the most ...

Idiopathic Intracranial Hypertension (IIH)
http://emedicine.medscape.com/article/1143167-overview

Jun 8th, 2022 - Practice Essentials Idiopathic intracranial hypertension (IIH) is a disorder of unknown etiology that predominantly affects obese women of childbearing age. [1] The primary problem is chronically elevated intracranial pressure (ICP), and the most ...

Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemore...
https://doi.org/10.1186/s13048-022-00999-x 10.3322/caac.21551 10.1210/endo.142.1.7897 10.1158/0008-5472.CAN-05-0425 10.1002/ijc.23086 10.3390/cancers13143399 10.1016/j.bbamcr.2013.02.002 10.1016/j.bbamcr.2012.05.024 10.1016/j.cmet.2014.03.011 10.15252/embj.201488349 10.1016/j.cell.2006.06.025 10.1083/jcb.201511036 10.1083/jcb.200906083 10.1042/BC20070110 10.1074/jbc.M114.594812 10.1074/jbc.M113.487686 10.1371/journal.pgen.1003021 10.1101/gad.460708 10.1038/onc.2013.447 10.1016/j.bbamcr.2008.05.013 10.1242/jcs.037655 10.1038/embor.2010.2 10.1158/0008-5472.CAN-06-1004 10.1101/cshperspect.a011106 10.1073/pnas.1208530110 10.1038/ncomms3126 10.1074/jbc.M111.314765 10.1038/sj.bjc.6604223 10.1038/nmeth947 10.18632/oncotarget.21076 10.1038/onc.2011.134 10.1371/journal.pone.0141826 10.1038/s41419-018-0661-3 10.1016/S0020-7292(00)90001-8 10.1006/gyno.2001.6552 10.2741/3364 10.1002/hep.28964 10.1016/j.lfs.2011.06.022 10.1038/s41418-019-0469-4 10.1007/s10495-015-1143-z 10.1038/sj.onc.1207444 10.1074/jbc.M305171200 10.1016/j.bbrc.2013.12.124 10.1158/0008-5472.CAN-12-0603 10.1073/pnas.1417253111 10.1002/embr.201338240 10.1074/jbc.M710539200 10.1253/circj.CJ-14-0240
Journal of Ovarian Research; Kong B, Han CY et. al.

Jun 7th, 2022 - Mitochondrial dynamics (e.g. fission/fusion) play an important role in controlling chemoresistance in representative gynecologic malignancies, ovarian and cervical cancer. Processing the long form of Optic atrophy (L-Opa)1 is a distinctive charact...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  22 results

Natural History Study of ATP1A3-related Disease
https://clinicaltrials.gov/ct2/show/NCT03857607

Jun 6th, 2022 - Alternating hemiplegia of childhood (AHC) is a rare very disabling neurodevelopmental syndrome caused by mutations in the gene ATP1A3. AHC is characterized by paroxysmal events including attacks of hemiplegia (weakness), dystonia (painful stiffeni...

ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
https://clinicaltrials.gov/ct2/show/NCT02377271

Apr 12th, 2022 - The main objective of our study will be to compare the treatment with bosentan to placebo for 8 weeks for recovery anatomical criteria (RFNL in OCT, optic atrophy) and functional (visual acuity, visual field). The primary endpoint will be the impr...

Stem Cell Ophthalmology Treatment Study II
https://clinicaltrials.gov/ct2/show/NCT03011541

Apr 6th, 2022 - Eyes with loss of vision from retinal or optic nerve conditions generally considered irreversible will be treated with a combination of injections of autologous bone marrow derived stem cells isolated from the bone marrow using standard medical an...

Safety and Efficacy of Etravirine in Friedreich Ataxia Patients
https://clinicaltrials.gov/ct2/show/NCT04273165

Mar 31st, 2022 - Friedreich ataxia is a rare progressive neurodegenerative disease presenting in childhood or late adolescence for which no treatment is currently available. The disease is caused by the defective synthesis of Frataxin, a mitochondrial protein synt...

GLP Analogs for Diabetes in Wolfram Syndrome Patients
https://clinicaltrials.gov/ct2/show/NCT01302327

Mar 29th, 2022 - Wolfram syndrome, also referred to as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy and deafness) is a genetic syndrome characterized by beta-cell dysfunction and apoptosis leading to diabetes, neurodegeneration and psychiatric ill...

see more →

News  16 results

Clinical Presentation of Subacute Combined Degeneration in a Patient With Chronic B12 Deficiency
https://www.mdedge.com/fedprac/article/252920/neurology/clinical-presentation-subacute-combined-degeneration-patient
Nathan Kostick, Evan Chen et. al.

Mar 21st, 2022 - Subacute combined degeneration (SCD) is an acquired neurologic complication of vitamin B12 (cobalamin) or, rarely, vitamin B9 (folate) deficiency. SCD is characterized by progressive demyelination of the dorsal and lateral spinal cord, resulting i.

Cachexia Common in Lupus
https://www.medpagetoday.com/rheumatology/lupus/87893

Aug 4th, 2020 - Cachexia is an underappreciated complication of systemic lupus erythematosus, researchers reported. A total of 56.3% of patients developed the involuntary weight loss accompanied by loss of homeostatic control of protein and energy balance within ...

A 10-Year-Old Boy With Fainting Spells and Seizure Activity
https://reference.medscape.com/viewarticle/884107_6

Sep 25th, 2019 - Question 1 of 2 Which of the following conditions is not associated with congenital LQTS? Your Peers Chose: Congenital sensorineural hearing loss 0% Congenital optic atrophy 0% Syncopal attacks 0% Seizures 0% Sudden cardiac death 0% Important clue...

see more →

Patient Education  1 results see all →